Login to Your Account



Clinic Roundup


Monday, March 19, 2012
• SK Biopharmaceuticals, of Seoul, South Korea, said it dosed the first patient in a Phase II trial of YKP10811, a selective partial agonist of serotonin Type 4 receptors, in chronic constipation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription